Cargando…
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system
The newly emerged severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) coronavirus initiated a pneumonia outbreak (COVID-19) that rapidly spread worldwide and quickly became a public health emergency of international concern; However to date, except Remdesivir, there are no clinically approv...
Autores principales: | Zhu, Qingyuan, Zhang, Yaling, Wang, Li, Yao, Xiangyu, Wu, Daitze, Cheng, Junjun, Pan, Xiaoyu, Liu, Haixia, Yan, Zhipeng, Gao, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801822/ https://www.ncbi.nlm.nih.gov/pubmed/33444702 http://dx.doi.org/10.1016/j.antiviral.2021.105015 |
Ejemplares similares
-
A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms
por: Zhu, Qingyuan, et al.
Publicado: (2020) -
STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021) -
Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023) -
Trial watch: STING agonists in cancer therapy
por: Le Naour, Julie, et al.
Publicado: (2020) -
Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
por: Ohkuri, Takayuki, et al.
Publicado: (2017)